Free Trial

Bank of America Corp DE Decreases Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Acadia Healthcare logo with Medical background

Bank of America Corp DE decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 86.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 98,462 shares of the company's stock after selling 652,958 shares during the quarter. Bank of America Corp DE owned 0.11% of Acadia Healthcare worth $3,904,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ACHC. FMR LLC lifted its position in shares of Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Khrom Capital Management LLC bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $49,602,000. Freestone Grove Partners LP bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $29,943,000. Magnetar Financial LLC lifted its position in shares of Acadia Healthcare by 385.4% during the 4th quarter. Magnetar Financial LLC now owns 928,772 shares of the company's stock worth $36,826,000 after buying an additional 737,427 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Acadia Healthcare by 18.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock worth $126,189,000 after buying an additional 486,395 shares during the last quarter.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of recent research reports. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Mizuho lowered their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Guggenheim started coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Barclays decreased their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Finally, Royal Bank of Canada decreased their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Get Our Latest Report on Acadia Healthcare

Acadia Healthcare Stock Down 0.4%

NASDAQ:ACHC traded down $0.08 on Friday, hitting $22.77. The stock had a trading volume of 1,666,930 shares, compared to its average volume of 1,718,782. The business's fifty day moving average is $25.09 and its 200 day moving average is $34.31. The company has a market cap of $2.10 billion, a PE ratio of 7.47, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. During the same period in the prior year, the firm posted $0.84 EPS. The firm's quarterly revenue was up .3% compared to the same quarter last year. On average, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines